key: cord-0946801-csajjewa authors: Haneef, Kabeer; Ghaffar Memon, Abdul; Saleem, Rabia; Batool, Farwa; Sadeeq, Mohd title: B cell receptor (BCR) guided Mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping date: 2021-07-06 journal: Med Hypotheses DOI: 10.1016/j.mehy.2021.110640 sha: 23c01b73aaa9c89ff6c0e0d87ae487b10f894dc9 doc_id: 946801 cord_uid: csajjewa Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, has spread around the globe with remarkable consequences for the health of millions of people. Despite the approval of mRNA vaccines to prevent the spread of infection, long-term immunity must still be monitored. Targeting and modifying virus receptor binding regions to activate B cell receptors (BCRs) is a promising way to develop long-term immunity against SARS-CoV-2. After the interaction of antigens, BCRs undergo series of signal transduction events through phosphorylation of immune receptor tyrosine activation motifs (ITAMs) to produce neutralizing antibodies against pathogens. BCRs intricate entity displays remarkable capability to translate the external mechanosensing cues to reshape the immune mechanism. However, potential investigations suggesting how SARS-CoV-2 specific B cells respond to mechanosensing cues remain obscure. This study proposes a sophisticated hypothesis explaining how B cells isolated from the CP of SARS-CoV-2 infected patients may undergo a triggered series of B cell activation, BCR dynamics, proximal signalling, and antibody production on PDMS-embedded in-vitro antigen-presenting structures (APCs). These studies could provide detailed insights in the future for the development of structural and therapeutic entanglements to fight against pathogens. 49 The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 50 is a positive-sense single-stranded RNA virus identified as the causative agent of COVID-51 19 (1). Similar to the other viruses of the coronaviridae family, the virus principally infects 52 respiratory airways, exhibiting symptoms ranging from mild respiratory infections to 53 severe acute respiratory syndrome (2,3). Long-term effects of the virus may result in 54 organ failure in some patients, ultimately leading to death (4). Long incubation periods 55 and the asymptomatic nature of SARS-CoV-2 make the diagnosis of infection challenging 56 and may contribute to transmission (5, 6) . The approval of anti-viral drugs such as 57 remdesivir, monoclonal antibodies against S protein, and Pfizer and BioNTech's mRNA 58 vaccines provide a pathway to mitigate the spread and disease severity (7). However, Although 78 Interestingly, these coherent investigations could trigger antibody production events in 79 the future that may be helpful in the production of vaccines providing long-term immunity. 80 Additionally, in the future, these mechanosensing entanglements may be used in 81 conjunction with direct structural therapeutics. This study also highlights a sequential long-term immunity is still essential to prevent the continued spread of COVID-19 infection 60 and re-establish normal socio-economic activities During SARS-CoV-2 infection, B cells may contribute significantly to producing antibodies 62 through delicate interactions of BCRs with antigens (11) These activities result in the onset of series of events, including 67 cellular proliferation (13,14), differentiation of B cells into plasma and memory B cells 68 (15,16), isotype antibody switching, maturation, and production of antibodies to combat 96 B cell activation and BCR-mediated signalling have been investigated using elastomers 97 fabricated from polydimethylsiloxane (PDMS) with varying rigidity properties Innate and adaptive immune cells retain a sophisticated mechanism to sense the minute 99 external mechanosensing features (20,21), and in response, generate efficient chemical 100 signals to reshape downstream series of events (12). Interestingly, PDMS and PA such as activation (12,22), cytoskeleton dynamics (23), and membrane-103 proximal recruitment of signalling molecules in B cells immunological synapse (IS) 104 Nevertheless, using the strategies mentioned earlier, a triggered level of NAbs could be 110 achieved by instructing B cells on mechanosensing featured topographies The sophisticated mechanism through which vaccines work reflects proximal correlation 112 with B cells and suggests potential mechanistic capability describing how BCR undergoes 113 signal transduction events to balance the immune mechanism (32) Interestingly, following the prescribed trajectory, B cells through 116 delicate interactions with SARS-CoV-2 structural catalogs could achieve specific 117 mechanisms, including (1) intricate triggered production of SARS-CoV-2 specific 179 structural antigens on PDMS elastomers, can be used to culture, harvest, and instruct B 180 cells. Following BCR's interactions with SARS-CoV-2 antigens on in-vitro APCs These events led to the subsequent recruitment and site specif 183 membrane-proximal accumulation of signalling subunits and adaptor proteins to intensify 184 the immune cascade events (12). A mixture of several B cells and cell lines (A-20, CH-185 27, J55L) could be employed to teach immune responses using the methodologies as 186 mentioned above. In this case, purified SARS-CoV-2 structural antigens could be 187 implanted on PDMS gel initially fixed with 5% BSA material. This approach can be 188 successfully used against SARS-CoV-2 and other pools of viruses Although, such a scenario might create obstacles in acquiring a 194 conclusion. For that reason, initially, SARS-CoV-2 developed surface density features, 195 and comparable accessibility to antibodies should be confirmed through quantifying the 196 mean fluorescence intensity (MFI) and total fluorescence intensity (TFI) profile. Another 197 feature could be differential surface rigidity features of PDMS in Furthermore, in-vitro culture and maintenance of splenic primary B cells are complex B cells could be stimulated with lipopolysaccharide (LPS) or SARS-CoV-2 201 structural antigens and subjected to in-vitro culture to analyze antibody production to 202 decipher the antibody production aptitude better 207 which should be well considered during anti-SARS-CoV-2 antibody production using 208 BCRs transduced mechanotransduction pathways. ADE phenomenon has been 209 observed in SARS-CoV-2 and some other viral infections, including dengue and 210 respiratory syncytial virus (RSV) (44) CoV-2 antibodies ineffective (39), it is imperative to address ADE in the context of efforts 212 to create countermeasures against SARS-CoV-2 via the mechanotransduction pathway Primary B cells isolated from the CP of infected individuals should be used as a model to 214 assess the ADE phenomenon of antibodies produced. It has been investigated that 215 people infected with SARS-CoV-2 exhibit enhanced antibody responses for a long time Therefore, it is advisable to construct a library of SARS-CoV-2 antigens-specific BCRs 217 from CP of infected people and fully express model B cell lines to interact with epitope An additional critical feature to examine is an assessment of neutralizing potential of anti In 223 that case, it's plausible to assess neutralizing potential of anti-SARS-CoV-2 antibodies 271 vaccine against novel coronavirus SARS-CoV-2. Microb Pathog B-cell engineering: A promising approach towards vaccine development 275 for COVID-19 Structural and immunogenomic 278 insights into B-cell receptor activation The coordination between B 282 cell receptor signaling and the actin cytoskeleton during B cell activation B lymphocytes: How they develop and function 287 Expansion of plasmablasts and loss of memory B cells in peripheral blood from 288 COVID-19 patients with pneumonia Available from: 294 of B cells encountering antigens with different motion features Cell Activation Is 297 Regulated by the Stiffness Properties of the Substrate Presenting the Antigens The activation of IgM-or 301 isotype-switched IgG-and IgE-BCR exhibits distinct mechanical force sensitivity 302 and threshold Mechanosensing through 304 immunoreceptors Mechanotransduction in 307 T Cell Development B cell mechanosensing: A 309 mechanistic overview Available from: 317 Regulated by the Stiffness Properties of the Substrate Presenting the Antigens Substrate stiffness governs 320 the initiation of b cell activation by the concerted signaling of PKCĪ² and focal 321 adhesion kinase Total chemical synthesis 323 of photoactivatable proteins for light-controlled manipulation of antigen-antibody 324 interactions Interfacial actin protrusions mechanically enhance killing by cytotoxic T cells Investigating cell mechanics with atomic force microscopy Nanotopography Influences Adhesion, Spreading, and Self-Renewal of Human 333 Embryonic Stem Cells Engineering Substrate Topography at the 336 Nanoscale to Control Cell Function Rational 342 HIV Immunogen Design to Target Specific Germline B Cell Receptors Detection of SARS-CoV-346 2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals Molecular Pathogenesis, 350 Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19 Genetic analysis of B cell signaling Reduced 355 neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera Substrate stiffness regulates 358 B-cell activation, proliferation, class switch, and T-cell-independent antibody 359 responses in vivo Profiling the origin 365 Quantification of cell edge velocities and traction forces reveals distinct motility 366 modules during cell spreading Mechanosensing in 368 T Lymphocyte Activation CRISPR/Cas9-generated models 372 uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP 373 inhibition Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities 377 to bind and activate Lyn and Syk tyrosine kinases Antibody-dependent enhancement Plotkin SA. Correlates of Protection Induced by Vaccination